ClinicalTrials.gov
ClinicalTrials.gov Menu

Tonabersat in the Prophylaxis of Migraine With Aura

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00332007
Recruitment Status : Completed
First Posted : May 31, 2006
Last Update Posted : August 31, 2009
Sponsor:
Collaborator:
University of Copenhagen
Information provided by:
Minster Research Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2008
  Actual Study Completion Date : August 2008
Publications of Results:
Other Publications:
International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine (second edition). Cephalalgia 2000; 20:765-86. Committee for Proprietary Medicinal Products. Note for guidance on clinical investigation of medicinal products for the treatment of migraine, CPMP/EWP/788/01/Final. London, 17 December 2003.
Committee for Proprietary Medicinal Products. Note for guidance on clinical investigation of medicinal products for the treatment of migraine, CPMP/EWP/788/01/Final. London, 17 December 2003.